IMR Press / EJGO / Volume 36 / Issue 6 / DOI: 10.12892/ejgo2627.2015

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Decreased expression of SIRT6 promotes tumor cell growth correlates closely with poor prognosis of ovarian cancer
G. Zhang1Z. Liu1S. Qin2K. Li2,3,*
Show Less
1 Department of Gynaecology and Obstetrics, Affiliated Qianfoshan Hospital of Shandong University, Jinan city
2 Institute of Materia Media, Shandong Academy of Medical Sciences, Jinan city
3 Department of Gynaecology and Obstetrics, Affiliated Hospital of Shandong Academy of Medical Sciences, Jinan city (China)
Eur. J. Gynaecol. Oncol. 2015, 36(6), 629–632;
Published: 10 December 2015

Introduction: Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread is not controlled, it can result in death. Sirtunins belong to a protein family and it is present in all organisms. SIRT6 is downregulated in tumor and acts as tumor suppressor. These sirtunin proteins are linked to repair DNA and metabolism. Material and Methods: To measure the role of SIRT6 in tumor cell, 20 mice were used and European Collection of Cell Cultures (ECACC) cell lines were used for the analysis. A histopathological technique showed the level of tumor cells. Results: A recent study provided exceptional insight into the mechanism of SIRT6-related chromatin regulation. According to the histopathology of cancer, SIRT1 localizes to the promoters of several aberrantly silenced tumor suppressor genes whose DNA is hypermethylated. SIRT1 has a role associated with the epigenetic hallmarks of cancer. Conclusion: The link between SIRT6 and cancer provide new insight into the therapeutic potential of small molecule activators or specific targets of SIRT6 for the prevention and treatment of cancer. Further investigation into the specific mechanism of SIRT6 is required to realize this potential.
Ovarian cancer
SIRT6 expression
Back to top